INVION COMPLETES DOSING IN KEY PHASE II CLINICAL TRIAL OF ORAL

INVION COMPLETES DOSING IN KEY PHASE II CLINICAL TRIAL OF ORAL
Brisbane, Australia and Delaware, United States: 29 June 2015: Invion Limited (ASX: IVX), an Australian drug development company, is pleased to announce that it has completed dosing in INVSC001: “Efficacy and safety of beta-adrenoceptor inverse agonist …
Read more on PharmiWeb.com (press release)

Broad: We have to play to our style
The last Ashes series, played in the winter of 2013/14, threatened to boil over on a number of occasions, most notably in Brisbane when Michael Clarke and Jimmy Anderson were involved in a heated confrontation which saw the former charged by the …
Read more on Malvern Gazette

Why I Love: surrounding myself with venomous critters
Understanding venoms is also crucial for the development of antivenoms, as snakebite is a major medical issue in developing countries. For someone like me studying the evolution of exochemistry, the natural world is an inexhaustibly rich source of …
Read more on Brisbane Times